Jean Nichols
Keine laufenden Positionen mehr
Karriereverlauf von Jean Nichols
Ehemalige bekannte Positionen von Jean Nichols
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Präsident | - | 26.04.2011 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Stonegate Partners LLC
 Stonegate Partners LLC Financial ConglomeratesFinance Stonegate Partners LLC is a private equity firm. | Geschäftsführer | - | - |
Seragen, Inc.
 Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Präsident | - | - |
Ausbildung von Jean Nichols
| The University of North Carolina at Charlotte | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| President | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Seragen, Inc.
Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Health Technology |
Stonegate Partners LLC
Stonegate Partners LLC Financial ConglomeratesFinance Stonegate Partners LLC is a private equity firm. | Finance |
- Börse
- Insiders
- Jean Nichols
- Erfahrung
